Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Some individuals experience appetite suppression quickly regardless of which treatment they use
Retatrutide, a once-weekly injection, makes the body more efficient at regulating appetite, digestion, and energy expenditure by activating these three receptors: Glucose-dependent insulinotropic polypeptide (GIP) Glucagon-like peptide 1 (GLP-1) Glucagon (GCG) Phase-2 clinical trial data published in the New England Journal of Medicine showed that the drug is effective for weight loss
However, patient safety must remain the priority
In addition, GLP-1 weight loss medications should not be used in the following situations: Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2
:max_bytes(150000):strip_icc()/GettyImages-2169095535-f8d8276415dd4300a867a1f8b7de098f.jpg)
